Log In
Print
BCIQ
Print
Print this Print this
 

Lifitegrast (SAR 1118, SHP606)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionEye drop formulation of a small molecule integrin beta(2) (LFA-1; MAC-1; CD18) antagonist
Molecular Target Integrin beta(2) (LFA-1) (MAC-1) (CD18)
Mechanism of ActionLFA-1 (CD11a-CD18) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today